LONDON (Alliance News) - LiDCO Group PLC Wednesday said said the US Food and Drug Administration had cleared the sale of the CNSystems' continuous non-invasive blood pressure monitoring module with the company's LiDCOrapidv2 monitor with Unity software.
The system monitors level of consciousness and blood flow together on one monitor, allowing doctors to more closely control both anesthesia and fluids.
The blood pressure monitoring technology company's shares were up 3.7% at 15.9375 pence early Wednesday.
By Steve McGrath; stevemcgrath@alliancenews.com; @SteveMcGrath1
Copyright 2013 Alliance News Limited. All Rights Reserved.